232 related articles for article (PubMed ID: 27729247)
1. High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells.
Osman I; Poulose N; Ganapathy V; Segar L
Eur J Pharmacol; 2016 Nov; 791():703-710. PubMed ID: 27729247
[TBL] [Abstract][Full Text] [Related]
2. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
4. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
[TBL] [Abstract][Full Text] [Related]
5. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
Perez J; Torres RA; Rocic P; Cismowski MJ; Weber DS; Darley-Usmar VM; Lucchesi PA
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C242-51. PubMed ID: 21451101
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
Shawky NM; Segar L
Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
[TBL] [Abstract][Full Text] [Related]
8. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
[TBL] [Abstract][Full Text] [Related]
9. Meso-dihydroguaiaretic acid inhibits rat aortic vascular smooth muscle cell proliferation by suppressing phosphorylation of platelet-derived growth factor receptor beta.
Song MC; Kim EC; Kim WJ; Kim TJ
Eur J Pharmacol; 2014 Dec; 744():36-41. PubMed ID: 25261039
[TBL] [Abstract][Full Text] [Related]
10. Camptothecin inhibits platelet-derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells through inhibition of PI3K/Akt signaling pathway.
Park ES; Kang SI; Yoo KD; Lee MY; Yoo HS; Hong JT; Shin HS; Kim B; Yun YP
Exp Cell Res; 2013 Apr; 319(7):982-91. PubMed ID: 23328306
[TBL] [Abstract][Full Text] [Related]
11. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.
Yoo KD; Park ES; Lim Y; Kang SI; Yoo SH; Won HH; Lee HP; Kim YH; Yoo ID; Yoo HS; Hong JT; Yun YP
Vascul Pharmacol; 2012; 56(1-2):91-7. PubMed ID: 22166585
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation.
Martin-Garrido A; Williams HC; Lee M; Seidel-Rogol B; Ci X; Dong JT; Lassègue B; Martín AS; Griendling KK
PLoS One; 2013; 8(11):e79657. PubMed ID: 24236150
[TBL] [Abstract][Full Text] [Related]
13. Taurine suppresses platelet-derived growth factor (PDGF) BB-induced PDGF-beta receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells.
Yoshimura H; Nariai Y; Terashima M; Mitani T; Tanigawa Y
Biochim Biophys Acta; 2005 Sep; 1745(3):350-60. PubMed ID: 16112211
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade.
Chen S; Dong S; Li Z; Guo X; Zhang N; Yu B; Sun Y
Cell Physiol Biochem; 2017; 44(1):215-228. PubMed ID: 29131001
[TBL] [Abstract][Full Text] [Related]
15. Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway.
Park ES; Lim Y; Hong JT; Yoo HS; Lee CK; Pyo MY; Yun YP
Vascul Pharmacol; 2010; 53(1-2):61-7. PubMed ID: 20398797
[TBL] [Abstract][Full Text] [Related]
16. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
Seo J; Lee HS; Ryoo S; Seo JH; Min BS; Lee JH
Eur J Pharmacol; 2011 Dec; 673(1-3):56-64. PubMed ID: 22040922
[TBL] [Abstract][Full Text] [Related]
17. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of BST406, a newly synthesized benzylideneacetophenone derivative, on abnormal vascular smooth muscle cell proliferation.
Kim TJ; Han HJ; Kim YJ; Jung JC; Yu JY; Lee JJ; Yun YP
Biol Pharm Bull; 2010; 33(5):900-4. PubMed ID: 20460774
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.
Begum N; Hockman S; Manganiello VC
J Biol Chem; 2011 Jul; 286(29):26238-49. PubMed ID: 21632535
[TBL] [Abstract][Full Text] [Related]
20. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
Chang Y; Li JY; Jayakumar T; Hung SH; Lee WC; Manubolu M; Sheu JR; Hsu MJ
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
